KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Short-term Investments (2016 - 2026)

Medtronic's Short-term Investments history spans 12 years, with the latest figure at $6.7 billion for Q2 2025.

  • For Q2 2025, Short-term Investments changed 0.39% year-over-year to $6.7 billion; the TTM value through Apr 2025 reached $6.7 billion, changed 0.39%, while the annual FY2025 figure was $6.7 billion, 0.39% changed from the prior year.
  • Short-term Investments for Q2 2025 was $6.7 billion at Medtronic, up from $6.5 billion in the prior quarter.
  • Across five years, Short-term Investments topped out at $7.8 billion in Q4 2021 and bottomed at $6.4 billion in Q2 2023.
  • The 5-year median for Short-term Investments is $6.8 billion (2022), against an average of $7.0 billion.
  • The largest annual shift saw Short-term Investments rose 6.11% in 2021 before it fell 14.54% in 2023.
  • A 5-year view of Short-term Investments shows it stood at $7.8 billion in 2021, then dropped by 11.71% to $6.9 billion in 2022, then decreased by 6.46% to $6.4 billion in 2023, then rose by 1.81% to $6.5 billion in 2024, then rose by 3.29% to $6.7 billion in 2025.
  • Per Business Quant, the three most recent readings for MDT's Short-term Investments are $6.7 billion (Q2 2025), $6.5 billion (Q3 2024), and $6.7 billion (Q2 2024).